Patrick Consultant compensation by year
Twist Bioscience Summary Compensation Table · the one fiscal year held| Component | FY2022 |
|---|---|
| Salary | $418,000 |
| Bonus | $0 |
| Stock awards | $1,888,673 |
| Option awards | $0 |
| Non-equity incentive | $0 |
| Pension and deferred compensation | $0 |
| All other | $122,770 |
| Total | $2,429,443 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Twist Bioscience Corp DEF 14A filed January 6, 2023, accession 0001104659-23-001907, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Twist Bioscience Corp filed document, accession 0001104659-23-001907. Every figure is read from that document and cited to the page and table it appears in. Filed January 6, 2023.
Twist Bioscience’s named executive officers, FY2022
as the company reported each| Named executive officer | Role | FY2022 total |
|---|---|---|
| Emily Leproust | Chief Executive Officer and Chair of the Board | $5,917,663 |
| James Thorburn | Chief Financial Officer | $2,705,683 |
| Patrick Finn | President and Chief Operating Officer | $2,690,452 |
| William Banyai | Senior Vice President of Advanced Development and General Manager of Data Storage | $2,634,318 |
| Patrick Consultant · this page | Former Chief Operating Officer | $2,429,443 |
| Dennis Cho | Senior Vice President, General Counsel, Secretary and Chief Ethics and Compliance Officer | $1,960,718 |
The full Twist Bioscience compensation record
free company briefThis page is one person within Twist Bioscience's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Twist Bioscience proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Twist Bioscience's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.